European shares fell again on Tuesday as heavyweight stocks like Novo Nordisk slumped, while U.S. President Donald Trump’s vocal attacks on Federal Reserve Chair Jerome Powell shook investor confidence which is already fragile due to concerns over the trade war.
Novo Nordisk (NOVOb.CO), opens new tab dropped 8% after U.S. rival Eli Lilly’s (LLY.N), opens new tab experimental pill worked as well as the Danish drugmaker’s blockbuster drug Ozempic to lower weight and blood sugar in a trial of diabetes patients.
The pan-European STOXX 600 index (.STOXX), opens new tab was down 0.7% as of 0709 GMT.
Concerns over U.S. tariffs also kept investors on the edge as they returned from the Easter long weekend.
Read also: Nigeria Eurobond yields dip as global trade fears cool
The week began on a dour note after Trump repeated his criticism of Powell to pressure the central bank into cutting interest rates quickly, raising concerns about its independence and igniting a sharp selloff on Wall Street on Monday.
Biotage (BIOT.ST), opens new tab shares surged 55.8% after the Swedish biotechnology firm said KKR made a cash offer for the firm, valuing it at around 11.6 billion Swedish crowns ($1.22 billion).
